By contrast, transgenic mice with the ability to delete α-SMA-expressing fibroblasts in pancreatic cancer developed invasive, undifferentiated tumors with enhanced hypoxia, epithelial-to-mesenchymal transition, and cancer stem cells, with diminished animal survival[25]. This evidence concerns the gene ACTA1 and pancreatic neoplasm.